Top 6 alternative sites to sprycel.com

  1. sprycel-hcp.com
    sprycel-hcp.com
  2. SPRYCEL (dasatinib) for Healthcare Professionals
    Find SPRYCEL indicated for the treatment of pediatric patients with newly diagnosed Ph+ acute lymphoblastic leukemia (ALL) with chemotherapy&for adults & children with Philadelphia Chromosome-positive Chronic Myeloid Leukemia (CML) (See indications below)

  3. biozenta.com
    biozenta.com
  4. Biozenta Lifescience is manufacturer of Oncology, Cytotoxic, Anticancer products-Biozenta Oncology

  5. specialitypharma.com
    specialitypharma.com
  6. Speciality Pharma Network | UFDA Approved Drugs | Generic Version of Drugs | New Delhi India
    Call at 9599377390, 9810280893 to Mr. Tanuj for procurement of UFDA Approved Drugs, Generic Version of Drugs. Used for treatment. Available in India.
    Author: Specialty Pharma; New Delhi; India

  7. yervoy.com
    yervoy.com
  8. Could YERVOY® (ipilimumab) be right for you?
    YERVOY is a prescription medicine used in adults and children 12 years of age and older to treat melanoma. See Indication, Important Safety Information, and Boxed Warning.

  9. vimpat.com
    vimpat.com
  10. Patient Information for VIMPAT® (lacosamide) CV
    VIMPAT is a prescription medicine used in people 4 years of age and older to treat partial-onset seizures and with other medicines to treat primary generalized tonic-clonic seizures. It is not known if VIMPAT is safe and effective in children under 4 years of age. See Important Safety Information.

  11. siklosusa.com
    siklosusa.com
  12. Hydroxyurea-based treatment for pediatric patients with sickle cell anemia – Siklos® (hydroxyurea)
    Siklos® is the first and only FDA-approved prescription medicine that is used to reduce the frequency of painful crises and reduce the need for blood transfusion in children, 2 years of age and older, with sickle cell anemia with recurrent moderate to severe painful crises. See Important Safety Information and Boxed Warning about myelosuppression and malignancies.
    Author: Super User